Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 1/20 | 0.64 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.61 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.61 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.61 |
| ▸ | ACE | P12821 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30010857 | 1.00 | MME (0.64) | MMEOPRM1OPRD1OPRK1ACE | |
| SCHEMBL30735514 | 1.00 | MME (0.64) | MMEOPRM1OPRD1OPRK1ACE | |
| SCHEMBL29577239 | 1.00 | MME (0.64) | MMEOPRM1OPRD1OPRK1ACE | |
| SCHEMBL30011943 | 1.00 | MME (0.64) | MMEOPRM1OPRD1OPRK1ACE | |
| SCHEMBL31472984 | 1.00 | MME (0.64) | MMEOPRM1OPRD1OPRK1ACE | |
| SCHEMBL8665198 | 1.00 | MME (0.64) | MMEOPRM1OPRD1OPRK1ACE | |
| SCHEMBL8713686 | 1.00 | MME (0.64) | MMEOPRM1OPRD1OPRK1ACE | |
| SCHEMBL29577429 | 1.00 | MME (0.64) | MMEOPRM1OPRD1OPRK1ACE | |
| SCHEMBL8665210 | 1.00 | MME (0.64) | MMEOPRM1OPRD1OPRK1ACE | |
| SCHEMBL30010701 | 1.00 | MME (0.64) | MMEOPRM1OPRD1OPRK1ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12246068-B2 | Enzymatically activatable peptide-redox modulator conjugates and use thereof | BRANDEIS UNIVERSITY (US) | 2025-03-11 | — | — | US | claimed |
| US-12246068-B2 | Enzymatically activatable peptide-redox modulator conjugates and use thereof | BRANDEIS UNIVERSITY (US) | 2025-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12246068-B2 | Enzymatically activatable peptide-redox modulator conjugates and use thereof | GPX1, GPX4, ENPEP | MME 533/4885OPRM1 4089/4885OPRD1 3831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.